BioMotiv
Overview
BioMotiv is a mission-driven therapeutic accelerator that funds and develops breakthrough discoveries from research institutions into medicines.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Amphista Therapeutics | Mar 2021 | Series B | Co-investor |
| Koutif Therapeutics | Sep 2017 | Accelerator | Lead |
| Allinaire Therapeutics | Jan 2017 | Seed | Co-investor |
| Aro Biotherapeutics | Jan 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioMotiv based?
BioMotiv is headquartered in Cleveland, Ohio, United States.
When was BioMotiv founded?
BioMotiv was founded in 2012.
How many portfolio companies does BioMotiv have?
BioMotiv has 4 portfolio companies in Caplight's dataset.
What are some companies in BioMotiv's portfolio?
Portfolio companies visible on Caplight include Amphista Therapeutics, Koutif Therapeutics, Allinaire Therapeutics, Aro Biotherapeutics.
What was BioMotiv's most recent investment shown here?
BioMotiv's most recent investment in this portfolio sample was in Amphista Therapeutics in 2021.
What sectors does BioMotiv focus on?
BioMotiv focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does BioMotiv focus on?
BioMotiv typically invests at the Early stage.
What is BioMotiv's AUM?
BioMotiv's assets under management are estimated between $100.0M and $250.0M.